FDA Investigator Thea C Grome

Thea C Grome has inspections in 7 countries as of 18 Oct 2023. Thea C Grome has collaborated with a combinined 3283 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
83
Last Inspection Date:
18 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, India, Poland, Malaysia, Netherlands, Mexico, Israel
Co-Investigator(s):
A Williams, Adam S Freeman, Alexander M Kay, Alford R Taylor, Alla Dubrovsky, Amanda E Lewin, PhD, Anderson, Andrea A Branche, Andrea George, PhD, Angel K Sandhu, Angela Shepas, Anh M Lac, Anthony E Keller, RPh, Arindam Dasgupta, PhD, Ashar P Parikh, Barbara A Crowl, Barbara J Wilcox, PhD, Calvin B Koerner, Carl Lee, Carole L Jones, CDR Rochelle B Young, RPh, MSA, CDR Sean T Creighton, Celeta S Coves, Charles A Snipes, PhD, Christine M Parmentier, Christopher R Czajka, Christopher W Buser, Cindy W Lewis, Craig A Garmendia, Da Lin Yao, MD, PhD, Daniel J Lahar, Daniel J Roberts, Daniel L Aisen, Darlene B Almogela, David G Eng, Deborah A Nebenzahl, Douglas Florentino, Dr. Mark J Seaton, PhD, Dr. Ralph M Bernstein, PhD, Dr. Zhou Chen (nmi), MD PhD, Dustin P Tran, Dustin R Abaonza, Edward D Haris, Edward D Harris, Edward D Vains, Elizabeth A Dakan, Emily Shacter, Eric J Heinze, Eric L Dong, BS, Eric W Anderson, Gene D Arcy, Geoffrey K Kilili, Gerald Feldman, Gerald M Feldman, PhD, Gerald N Mcgirl, DDS, Greg K Keshishyan, Harperd, Henry K Lau, Henry X Lau, Himanshu Gupta, PhD, Humberto Z Gomez, Ivar J Sohn, James A Lane, James R Evans, James R Fleckenstein, Jane M Kreis, Janet Pulver, Janete F Guardia, Jeanne Fringer, PhD, Jeanne J Thai, Jeffrey M Watson, Jeffrey S Buckser, Jeffrey W Shrifter, DPM, Jennifer C Adams, Jennifer L Degroot, Jennifer L Johnson, Jessica E Paulsen, Joan T Briones, Jocelyn T Ramos, Joseph A Seitz, Joseph Kutze, PhD, Joseph P Iser, MD, Joshua S Hunt, Juan A Morales, Juanita Banuelos, Jude C Dikes, Jyoti B Patel, PhD, Kara A Scheibner, PhD, Karen J Bak, Katlin N Stubbs, Kellia N Hicks, Kelvin Cheung, Kendra A Biddick, Kenya Destin, Keren Arkin, Kevin P Foley, Kristin M Abaonza, Lakecha N Lewis, Lakisha M Williams, Lance A Finnical, Lance M De Souza, MBA, Laree A Tracy, Laurie P Norwood, Lavender M Huskey, Laverne Puckett, LCDR Jennifer H Rhyu, Leonard H Lavi, Linda Linh T Nguyen, Linh Tu, Lori A Gioia, Lori J Silverstein, Lucila B Nwatu, Lydia S Chan, Mabel M Lee, Maida Henesian (NMI), Marie K Kinkade, Mariza M Jafary, Mark E Chan, Mark F Chan, Mark W Babbitt, Marsha W Major, Mary R Hole, Mathew T Thomas, MD, Matthew M Vernon, Melissa A Torres, Melkamu Getie Kebtie, PhD, Mendoza O Wallace, Michael Shanks, MS, Michelle Rfrazier Jessen, PhD, Mihaly S Ligmond, Min Shanma Liu, Mohsen Rajabi Abhari, FDA, Mpris Inspector, Nayan J Patel, Nayan Patel, Nicholas Obiri, PhD, Nicola M Fenty Stewart, Nicole M Bell, Nicole M Gillette, Omotunde O Osunsanmi, Paul M Kawamoto, Paula J Bretz, Peter E Baker, Peter Kessler, PhD, Quynh H Strandberg, Quynh Van Tran, Raymond T Oji, Rebecca Rodriguez, Rebecca T Davis, Riley C Myers, PhD, Robert D Tollefsen, Ruben C Ayala, PharmD, Sandra S Saniga, Scott B Laufenberg, Scott N Lim, Serge Beaucage, Sergio Chavez (NMI), Shelley H Beausoleil, Sherri J Jackson, Sherri N Rohlf, MD, Sidney B Priesmeyer, Sripal R Mada, PhD, Stephanie A Slater, MS, Stuart W Russell, Sunitha K Rajaram, PhD, Susan D Yuscius, Susanne M Richardson, MSc RAC ELS, Suzanne M Healy, Tania Y Hall, Tawny L Colling, Teena H Aiken, Thomas W Nojek, Thuy T Nguyen, LCDR, Timothy C Grome, Truong Xuan Nguyen (Andy), Uttaniti Limchumroon (Tom), William J Foust, William V Millar, Xiaohan Cai, PhD, Yi Wang, PhD, Young M Choi, PhD

Thea C Grome's Documents

Publish Date Document Type Title
June, 2017 FDA 483 Ultragenyx Pharmaceutical Inc. - Form 483, 2017-06-20
February, 2014 FDA 483 LumiQuick Diagnostics Inc. - Form 483, 2014-02-24
January, 2017 FDA 483 Charles River Laboratories, Inc - Form 483, 2017-01-13
January, 2017 EIR Charles River Laboratories, Inc - EIR, 2017-01-13
May, 2019 EIR Endologix, Inc. - EIR, 2019-05-24
May, 2019 FDA 483 Endologix, Inc. - Form 483, 2019-05-24
June, 2013 EIR Bayer Healthcare, LLC - EIR, 2013-06-26
October, 2020 EIR Corcept Therapeutics Incorporated - EIR, 2020-10-19
January, 2016 FDA 483 Jazz Pharmaceuticals, Inc - Form 483, 2016-01-27
April, 2016 EIR Santa Clara Valley Medical Center IRB - EIR, 2016-04-11
June, 2018 FDA 483 Soledad O. Lee, MD - Form 483, 2018-06-08
November, 2017 FDA 483 Rahul R. Aggarwal, MD - Form 483, 2017-11-21
October, 2015 FDA 483 Center For Dermatology Clinical Research, Inc. - Form 483, 2015-10-07
April, 2016 FDA 483 Santa Clara Valley Medical Center IRB - Form 483, 2016-04-11
June, 2017 EIR Ultragenyx Pharmaceutical Inc. - EIR, 2017-06-20
March, 2013 FDA 483 Hospira, Inc. US Service Center - Form 483, 2013-03-19
December, 2015 EIR Abbott Vascular - EIR, 2015-12-10
August, 2018 FDA 483 Oeyama-Moto Medical Foundation - Form 483, 2018-08-09
July, 2015 EIR 9 ayer Healthcare LLC - EIR, 2015-06-30
February, 2019 EIR Actelion Pharmaceuticals U.S., Inc. - EIR, 2019-02-28
August, 2014 EIR Stellartech Research Corporation - EIR, 2014-08-14
September, 2018 FDA 483 Linda Chao, PhD - Form 483, 2018-09-10
January, 2019 EIR John Day - EIR, 2019-01-22
April, 2015 FDA 483 Silk Road Medical Inc - Form 483, 2015-04-14
September, 2014 FDA 483 Incumedx LLC - Form 483, 2014-09-12
June, 2020 EIR Myovant Sciences, Inc. - EIR, 2020-06-30

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more